All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Argos Therapeutics Inc., of Durham, N.C., set a proposed price range for its planned initial public offering (IPO) of 4.3 million shares between $13 and $15.
